Frequent mutations in RAF, RAS, and PTEN are largely associated with defects in cell death machinery, abnormal proliferation, angiogenesis, and invasion and thereby contribute in great part to melanoma progression and drug resistance [19,20,137,197]. This evidence concerns the gene PTEN and melanoma.